题名 | A randomized phase III trial of olaparib as adjuvant therapy in patients with high-risk HER2-negative breast cancer (BC) and a germline BRCA 1/2 mutation (g BRCA m). |
杂志 | Journal of Clinical Oncology |
年|卷|期 | 33(15_suppl):TPS1109-TPS1109 |
链接 | https://ascopubs.org/doi/abs/10.1200/jco.2015.33.15_suppl.tps1109 |
欢迎光临 科研速递论坛 (http://www.expaper.cn/) | Powered by Discuz! X2.5 |